Loading…
Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites
Cryptosporidium is a genus of apicomplexan parasites infecting humans or other vertebrates. The majority of the Cryptosporidium species live in host intestines (e.g., C. parvum , C. hominis and C. ubiquitum ), but there are a few gastric species (e.g., C. muris and C. andersoni ). Among them, C. par...
Saved in:
Published in: | Frontiers in molecular biosciences 2022-11, Vol.9, p.1051072-1051072 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cryptosporidium
is a genus of apicomplexan parasites infecting humans or other vertebrates. The majority of the
Cryptosporidium
species live in host intestines (e.g.,
C. parvum
,
C. hominis
and
C. ubiquitum
), but there are a few gastric species (e.g.,
C. muris
and
C. andersoni
). Among them,
C. parvum
is the most important zoonotic species, for which a number of glycoproteins have been reported for being involved in the interacting with host cells. However, little is known on the cryptosporidium glycobiology. Information on the glycosylation pathways in
Cryptosporidium
parasites remains sketchy and only a few studies have truly determined the glycoforms in the parasites. Here we reanalyzed the
Cryptosporidium
genomes and reconstructed the glycosylation pathways, including the synthesis of
N
- and
O
-linked glycans and GPI-anchors. In
N
-glycosylation, intestinal
Cryptosporidium
possesses enzymes to make a simple precursor with two terminal glucoses on the long arm (i.e., Glc
2
Man
5
GlcNAc
2
vs. Glc
3
Man
9
GlcNAc
2
in humans), but gastric species only makes a simpler precursor containing only the “core” structure (i.e., Man
3
GlcNAc
2
). There is an ortholog of glucosidase II (GANAB) in all
Cryptosporidium
species, for which the authenticity is questioned because it contains no signal peptide and exist in gastric species lacking terminal glucoses for the enzyme to act on. In
O
-linked glycosylation, all
Cryptosporidium
species may attach one-unit HexNAc (GalNAc and GlcNAc) and two-unit Fuc-type (Man-Fuc) glycans to the target proteins.
Cryptosporidium
lacks enzymes to further process
N
- and
O
-glycans in the Golgi. The glycosylphosphatidylinositol (GPI)-anchor in
Cryptosporidium
is predicted to be unbranched and unprocessed further in the Golgi.
Cryptosporidium
can synthesize limited nucleotide sugars, but possesses at least 12 transporters to scavenge nucleotide sugars or transport them across the ER/Golgi membranes. Overall,
Cryptosporidium
makes much simpler glycans than the hosts, and the
N-
glycoforms further differ between intestinal and gastric species. The
Cryptosporidium N
- and
O
-glycans are neutrally charged and have limited capacity to absorb water molecules in comparison to the host intestinal mucins that are negatively charged and highly expandable in waters. |
---|---|
ISSN: | 2296-889X 2296-889X |
DOI: | 10.3389/fmolb.2022.1051072 |